Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients. Ding L, Han DM, Yan HM, Zhou JX, et al. Bone Marrow Transplant 2022;57:1086-1094.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ding L, Han DM, Yan HM, Zhou JX, et al. Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients. Bone Marrow Transplant 2022;57:1086-1094.
PMID: 35468947